IP Library Patent Application 13407642
Patent Application
App. No. 13/407,642

MINIMAL TISSUE ATTACHMENT IMPLANTABLE MATERIALS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/407,642
Abstract

A method for minimizing tissue adhesion at an injured site is provided, the method comprising applying a biocellulose material to the injured site, whereby the adhesion of the tissues at the injured site is minimized, wherein the biocellulose material is at least partially dehydrated. Another embodiment provides an implantable material, which effectively prevents cell adhesion and has desirable mechanical properties.

Claims (19)

1 . A method of making an implantable biocellulose material which minimizes tissue attachment, comprising:

(i) providing a biocellulose material;

(ii) oxidizing the biocellulose material;

(iii) de-pyrogenating the biocellulose; and

(iv) dehydrating the biocellulose material.

2 . The method in claim 1 , wherein the biocellulose material is oxidized using at least one of (i) nitrogen tetroxide and (ii) sodium periodate.

3 . The method of claim 1 , wherein the biocellulose has a tissue adhesion tenacity of less than about 2.

4 . The method of claim 1 , wherein a microstructure of the biocellulose material before step (i) is substantially the same as the microstructure of the biocellulose material after step (iv).

5 . The method of claim 1 , wherein the step of dehydrating the microbial cellulose is accomplished by a method selected from the group consisting of a solvent dehydration, supercritical drying method, lyophilization, controlled drying under constant humidity and thermal modification.

6 . The method of claim 1 , further comprising rehydrating the biocellulose material after step (iv).

7 . The method of claim 1 , wherein the biocellulose material is substantially free of a biologically active agent.

8 . The method of claim 1 , wherein the biocellulose material has an effective pore size of less than or equal to about 1 micron.

9 . The method of claim 1 , wherein the biocellulose material has at least one of

(i) a tensile strength of between about 1 N and about 300 N

(ii) a stiffness of between about 3 N and about 40 N)

(iii) a suture pull-out strength of between about 0.3 N and about 15 N.

10 . An implantable material made according to the method of claim 1 .

11 . The implantable material of claim 10 , wherein material prevents adhesions of at least one of the adjoining tissue or organ at an implantation site.

12 . The implantable material of claim 10 , wherein the material creates a plane of dissection at an implantation site.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2014
From: ELLIOT CAPITAL INVESTMENTS III, LTD.
To: SYNTHES USA PRODUCTS, LLC
Reel/Frame 033227/0223 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: XYLOS CORPORATION
To: ELLIOT CAPITAL INVESTMENTS III, LTD.
Reel/Frame 029120/0401 →